RANI Research and Charts

RANI - Rani Therapeutics Holdings Inc Class A (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 1.34	Change ⇑ +0.07 (+5.51%)	Volume 1,313,459
	Open 1.26	High 1.42	Low 1.26

8EMA (Daily) 1.26	40EMA (Daily) 1.36	50EMA (Daily) 1.36	STO (Daily) 37.894	MACD Hist (Daily) 0.013
8EMA (Weekly) 1.342	40EMA (Weekly) 1.29	50EMA (Weekly) 1.36	STO (Weekly) 13.289	MACD Hist (Weekly) -0.065


Company Profile
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.